EYPT ▲ +0.3% - EyePoint, Inc.
$EYPT - EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD
19-OCT-2026 07:00 AM ET
Share this post
More filings for $EYPT
EYPT ▲ +0.3% - EyePoint, Inc.Oct 19, 2026EYPT ▲ +0.3% - EyePoint, Inc.Oct 19, 2026EYPT - EyePoint, Inc. - SEC Filing Update (07-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 7, 2026EYPT ▲ +1.9% - EyePoint, Inc.Sep 16, 2026EYPT - EyePoint, Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026EYPT ▼ -2.0% - EyePoint, Inc.Sep 2, 2026
View full $EYPT filing history →💬 Comments
Loading comments…
Leave a comment